BioSpace News Archive

Catabasis Pharmaceuticals, Inc. today announced that Jill C. Milne, Ph.D., Chief Executive Officer, will present a corporate overview and provide information on its lead program QLS-215, which is in preclinical development for the treatment of hereditary angioedema, at the upcoming virtual Ladenburg Thalmann Healthcare Conference.

Nucleix, a liquid biopsy company revolutionizing cancer treatment by detecting the disease earlier, today announced the publication of an analysis highlighting that Bladder EpiCheck® can reduce both patient burden and healthcare system costs in the U.S. and European countries for low grade intermediate risk non-muscle invasive bladder cancer (NMIBC)

Verge Genomics today announced that data from preclinical studies using its novel PIKfyve inhibitor VRG101 showed broad spectrum of antiviral activity. The results will be presented at the 31st European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) online meeting being held July 9-12, 2021.

VBI Vaccines Inc. today announced that Linda Bain, Chief Financial Officer of Codiak BioSciences, Inc., has joined its Board of Directors.

Tenax Therapeutics Announces CEO Transition and $10 Million PIPE Offering Priced At-the-Market under Nasdaq Rules

UroGen Pharma Ltd today announced that it will present at the Ladenburg Thalmann Healthcare Conference on July 14, 2021 at 12:00pm Eastern Time.

ENDRA Life Sciences Inc. announces the strengthening of its global patent portfolio with the issuance of the 17 th , 18 th and 19 th patents from the United States Patent & Trademark Office (USPTO) for its TAEUS technology.

Biotricity, Inc. today announced preliminary revenue results guidance for its 2022 fiscal first quarter, ended June 30, 2021.

Solstice Pharmaceuticals has successfully completed its latest round of funding to further the clinical development of its innovative ultrasound contrast agent (UCA).

Today at the American Orthopaedic Society for Sports Medicine annual meeting, Marrow Access Technologies announced full US market release of the SmartShot Marrow Access Device.